The Microbiology Society is pleased to present Anaerobe 2021 in association with the Society for Anaerobic Microbiology. Anaerobic bacteria are predominant members of the normal human microbiota and well recognised as lethal pathogens. Aspects of their virulence, antimicrobial resistance and interactions with the human host will be highlighted during the Anaerobe 2021 Focused Meeting. Infectious diseases relating to Gram negative anaerobes including the Bacteroidetes, such as Bacteroides, Prevotella and Porphyromonas, will be discussed, as well as their role as drivers of diseases such as cancer and Alzheimer’s. The meeting will also include important clostridial infection and treatment updates.
Anaerobe 2021 will provide clinical microbiologists, infectious disease researchers and specialists with insights into the current and future impact of anaerobic bacteria in human health and disease. Researchers studying oral, gastrointestinal tract and female genital system microbiomes will gain key scientific insights into these important members of the microbiota and colonisers of humans.
Offered papers relating to aspects of anaerobic bacteria in human health and disease will be considered for presentation within the symposium.Joining Instructions for Anaerobe 2021: The Microbiota and Beyond
Image credit: iStock/DrMicrobe
Please find below more information about our invited speakers, who will present their work and research at Anaerobe 2021: the microbiota and beyond.
Joanne M. Santini is a Professor of Microbiology at UCL and Chair of the UCL Microbiology Domain. JMS obtained her PhD in Microbiology at La Trobe University, Melbourne, Australia in 1999. In 2000 she became an independent group leader and was awarded an Australian Research Council Australian Postdoctoral fellowship. She moved to London in 2006 as a lecturer in Environmental Biology at UCL. She is interested in all microbial life having worked on bacterial plasmids and bacterial conjugation, microbial metabolism of arsenic and more recently viruses, including host-range of SARS-CoV-2, and the gut microbiome of humans and animals with a particular focus on bacteriophages. Her collaboration with Jill Banfield (UC Berkeley) led to the recent discovery of the largest phage ever identified in the gut, designated Lak, which preys on Prevotella species. Twitter: @microbiologyucl
Mike Curtis is Professor of Microbiology at King’s College London and Dean of the Faculty of Dentistry, Oral and Craniofacial Sciences. His current research is focused on the oral microbiome, the microbial pathogenesis of periodontal disease and the relationship of oral health and disease to systemic conditions. His research involves biochemical, genetic and structural studies of Porphyromonas gingivalis and the use of animal models of disease to address mechanisms of pathogenesis using both conventionally housed and germ free mice. He was a visiting postdoctoral fellow at the NIH USA before joining the Medical Research Council as Senior Scientist. He then moved to QMUL where he led the Blizard Institute of cell and molecular sciences and subsequently the Institute of Dentistry. He joined King’s in 2017.
Dr. Boleij obtained her PhD on the association between infections with the opportunistic gut pathogen Streptococcus gallolyticus and gastrointestinal tumors. In 2012 she was awarded a Rubicon grant of NWO to conduct research on oncotoxin producing Bacteroides fragilis at Johns Hopkins Medical Institutions. Her research revealed the frequent detection of the oncotoxin in the gut mucosa of CRC patients and elucidated part of the epithelial signaling mechanism of this bacterial oncotoxin. In 2014 she started her research group at the Department of Pathology of the Radboudmc and was awarded a prestigious Veni-grant from NWO. With her research group Dr. Boleij focuses on members of the microbiome with potential cancer promoting or inhibiting effects especially in patients with a high risk for CRC. The ultimate goal is to understand whether microbes play a role in the pathogenesis of CRC and whether microbes can predict if patients are at increased risk. LinkedIn: Annemarie Boleij
Robert Fagan is a molecular microbiologist whose work for the past 16 years has focused on the anaerobic human pathogen Clostridioides difficile and related species. His lab at the University of Sheffield combines classical bacterial genetics, with protein biochemistry and structural biology by X-ray crystallography and cryo-EM. In addition to projects on the biogenesis and function of cell surface structures, sporulation and germination, the Fagan lab specialise in the development of new genetic tools and high-throughput methods for analysis of gene function.
Dr Daniel J. Slade is an Assistant Professor at Virginia Tech with training in chemistry, biochemistry, microbiology, molecular genetics, enzymology, and host-pathogen interactions. The long-term goal of his laboratory is to characterize how bacteria from the oral cavity disseminate to extraoral sites to participate in infection and cancer. His work is highly interdisciplinary and is incorporating biomedical engineering to understand how Fusobacterium nucleatum contributes to multiple cancers, including its role in the modulation of cancer severity, apoptosis inhibition, metastasis, and other uncharacterized molecular mechanisms. A continuing theme of his laboratory is to develop and improve genetic systems for successful chromosomal DNA editing in Fusobacterium.
Lindsay has recently been appointed as the Chair of Intestinal Microbiome at the Technical University of Munich (Germany) and is a Wellcome Investigator. She also holds a group leader position at the Quadram Institute (UK). The lab’s research focus involves defining microbe/microbiota interactions during the early life developmental window. She obtained a BSc in Microbiology from the University of Glasgow, a PhD in Microbiology and Immunology from the University of Cambridge (Wellcome Trust Sanger Institute), and was a postdoctoral fellow at University College Cork, Ireland (APC Microbiome Institute). She returned to the UK to take up a Senior Lectureship at the University of East Anglia before moving to Quadram end of 2015. Twitter: @hall_lab; Linkedin: Lindsay Hall
Dr Jane Freeman is a Clinical Scientist in microbiology at Leeds Teaching Hospitals Trust and an HEE/NIHR ICA Clinical Lecturer. She holds a visiting researcher position at the University of Leeds. She completed her PhD on Antibiotics and C. difficile with Prof Mark Wilcox in 2001, which was the start of a career-long interest in this organism. After a post-doctoral position in Prof. Wilcox' lab, Jane moved to the NHS to train as a clinical scientist, specialising in healthcare associated infections, and helping to establish the highly successful Healthcare Associated Infections Research group at Leeds - a multi-organisation research group bringing together academics and scientists from UoL, LTHT and PHE. Jane's particular research interests are antimicrobial resistance in C. difficile, gut dysbiosis and paediatric CDI; she is also a strong advocate of research careers and opportunities for healthcare scientists within the NHS. Twitter: @HCAILeeds
Michael is a registered Clinical Scientist in microbiology, deputy lead scientist for the UK Anaerobe Reference Unit (UKARU) and a Higher Specialist Scientist Trainee, based at Public Health Wales in Cardiff. He has led on the service development and implementation of molecular and sequencer-based methods for screening, diagnosis, and typing of infectious disease. Most recently, he was the lead scientist for the development a national ISO:15189 Accredited Clostridioides difficile Whole Genome Sequencing Single Nucleotide Polymorphism Typing Service in Wales. Michael is the chair of the Wales C. difficile Infection Focus Forum, a newly formed group designed to inform further improvement in the prevention and management of CDI in Wales.
The Microbiology Society is pleased to present a book of abstracts from our presented posters at the Anaerobe 2021 Focused Meeting.Anaerobe 2021 Poster Abstract Book
The Journal of Medical Microbiology ‘Most Promising Science Prize’ will be awarded to one offered paper at Anaerobe 2021. The prize will be awarded to a paper that presents particularly compelling or novel research in the journal’s subject field. The winner will receive a cash prize and a certificate. All offered oral papers at Anaerobe 2021 are automatically entered for the prize.
In addition to this, FEMS Microbiology Letters will be awarding a best poster prize, judged by the scientific organising committee of the meeting. The winner will receive a cash prize and a certificate.
Posters will be presented during two dedicated sessions throughout the meeting and will be viewable on the event platform from Monday 12 July. A poster abstract book will also be made available from this date.
The poster session times are below, please note all times are in BST:
Poster Session A: 15/07/2021, 19:00–20:00
Poster Session B: 16/07/2021, 17:55 –18:55
Each poster will have it's own dedicated breakout room in the sessions. Delegates will be able to navigate between the rooms to view posters within the hour slot.
Anaerobe 2021 will be accessible remotely and will use virtual event technology to provide a comprehensively curated scientific programme for the conference.
For the most stable and consistent experience, it is highly recommended that you use Google Chrome. Microsoft Edge is also compatible - depending on your browser’s security settings. Please note, the platform is not compatible with Internet Explorer, Firefox or Safari.Joining Instructions for Anaerobe 2021: The Microbiota and Beyond
Anaerobe 2021: The Microbiota and Beyond will include an event app.
This will be available as a free download for all registered delegates. It has primarily been designed to help you make personal connections with other attendees (subject to your permissions).
The software also offers live event notifications, personalised schedules across the whole of Annual Conference week and options to search all abstracts.
Society Conference Grants of up to £10 are available to support eligible members wishing to present at the Annual Conference. Support is also available for members requiring support for caring costs associated with conference attendance. Full information is available on the Society Conference Grant page.
Applications to the Society Conference Grant to support registration for the Anaerobe 2021 meeting are now closed.
If you are a member who is not eligible for a Society Conference Grant, please apply via the Travel Grant scheme (deadline: 1 June 2021).
Please contact [email protected] for further queries.
Registration is now open.
Members get heavily subsidised registration fees for Annual Conference, Focused Meetings and other Society events – both online and in-person. Join now to enjoy these discounts and many other opportunities that are designed for microbiologists at all stages of their career.
To ensure the meeting remains of value for the scientific community, small charges apply to reflect some of the incurred costs associated to delivering the online meeting.
Upon registration, you should receive an automated confirmation email. Please contact [email protected] if after 24 hours this has not been received.
All registration fees must be paid in full before the start of the event. Any outstanding registration fees must be paid before any joining instructions containing information on how to access the event are sent out.
Please inform the conferences team if you can no longer attend the event after registering by contacting [email protected]. Refunds are not provided; however, substitutions of attendees can be made at any time.
Sponsorship opportunities are available for this meeting.
Please download our sponsorship pack to view our exciting new digital options. Our options suit varying budgets and help create the opportunities you need to connect with new and existing customers. If you have any questions about the packages or the digital options available please email [email protected].Anaerobe 2021 Sponsorship Pack
Anaerobe 2021 Technical Specifications and Guidelines